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A B S T R A C T
Serodiagnosis of human anisakidosis is presently hampered by the current lack of standardised serological assays
that allow sensitive and speciﬁc detection of Anisakidae-speciﬁc antibodies in human patients. In the present
study, we comparatively evaluated the diagnostic value (by IgG-ELISA) of excretory-secretory antigens (ESAgs)
of Anisakis simplex, Pseudoterranova decipiens and Contracaecum osculatum, representing the most frequently
found genera responsible for human infection. In addition, we tested also a mix of the three ES preparations
(Mix-ESAgs) as well as two recombinant allergens of A. simplex, rAni s 1 and rAni s 7. ES antigen from C.
osculatum yielded the best diagnostic performance in IgG-ELISA-based serodiagnosis of the Spanish anisakidosis
patients investigated in this study (relative serodiagnostic sensitivity 100%; speciﬁcity 89%) as compared to A.
simplex ES-antigen (93% versus 57%) and P. decipiens (67% versus 93%) or a mix of the three ES antigens (100%
versus 44%), respectively. Cross-reactions of C. osculatum ES antigen with serum-antibodies from patients suf-
fering from other helminth infections were rare and were exclusively found with few sera from toxocariasis,
ascariasis, and ﬁlariasis patients. The two recombinant allergens rAni s 1 and rAni s 7 did not prove suﬃciently
sensitive and speciﬁc in order to justify a further evaluation of these antigens regarding their suitability in IgG-
ELISA-based serodiagnosis of human anisakidosis. In conclusion, the C. osculatum-ESAg-ELISA remains as key
candidate to be further assessed for the serodiagnosis of symptomatic anisakidosis in diﬀerent endemic regions.
1. Introduction
Human anisakidosis is a parasitic infection of the gastrointestinal
tract caused by the third-stage larvae (L3) of anisakid nematodes from
predominantly three genera of the Anisakidae family: Anisakis,
Pseudoterranova, and Contracaecum (Audicana and Kennedy, 2008).
The life cycle of anisakid nematodes involves marine ﬁsh, squid and
crustaceans as intermediate and/or paratenic hosts and marine mam-
mals as deﬁnitive hosts (Pozio, 2013). Humans are accidental hosts and
become infected by consuming raw or undercooked ﬁsh parasitized by
anisakid L3 larvae, most commonly of A. simplex, A. pegreﬃi and P.
decipiens; nevertheless, three sporadic cases due to C. osculatum have
been recorded from Germany (Schaum and Müller, 1967), Japan
(Nagasawa, 2012) and Australia (Shamsi and Butcher, 2011).
Human anisakidosis is highly endemic in Japan, which accounts for
up to 90% of global cases (Hochberg and Hamer, 2010). In Europe, the
burden of anisakidosis has been initially estimated to 500 cases per year
(Arizono et al., 2012; D'Amico et al., 2014), however, this is likely to be
an underestimate according to recent reports (Bao et al., 2017).
Pathogenic eﬀects of Anisakidae worms in humans depend on their
location within or outside the gastrointestinal tract, the anisakid genus
(Arizono et al., 2012) and the immune status (Audicana and Kennedy,
2008; Nieuwenhuizen, 2016). Gastric anisakidosis is the most common
subtype of the disease concerning 95% of cases, whereas intestinal
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anisakidosis accounts for the majority of the remaining (Caramello
et al., 2003). Anisakidosis cases of extra-gastrointestinal localization
are extremely rare (Hochberg and Hamer, 2010; Ramanan et al., 2013).
Allergic reactions are common in humans upon exposure to A.
simplex or A. pegreﬃi (Anadón et al., 2009; Mattiucci et al., 2013),
however it remains yet unknown whether or not Pseudoterranova spp.
and Contracaecum spp. can cause allergies in humans as well
(Buchmann and Mehrdana, 2016).
After ingestion of infected ﬁsh, incubation periods can vary from
hours (2–12 h) in gastric anisakidosis to days (2–5 days) in intestinal
infection (Ishikura et al., 1993; Takabayashi et al., 2014). Acute and
severe epigastric pain is the typical symptom of gastric anisakidosis,
while clinical manifestation of intestinal anisakidosis is mostly un-
speciﬁc, which makes an accurate diagnosis diﬃcult (Miura et al.,
2010; Shimamura et al., 2016; Tsukui et al., 2016).
Diagnosis of anisakidosis relies mainly on clinical features and a
history of consuming seafood in the preceding hours or days (Zullo
et al., 2010). Endoscopic visualization of L3 larvae is the unique
available approach to prove gastric and/or colon anisakidosis (Yoon
et al., 2004). Computed tomography scan of the abdomen showing
typical ﬁndings such as segmental edema of the intestinal wall and
ascites (Shimamura et al., 2016) can be applied to detect intestinal
infection. Nevertheless, intestinal anisakidosis remains the most com-
monly misdiagnosed subtype of the disease; indeed it is frequently
confused with bowel obstruction, inﬂammatory bowel disease or ap-
pendicitis (Chikamori et al., 2004; Yasunaga et al., 2010). Molecular
tools are only applied as conﬁrmatory test or for genetic identiﬁcation
of the parasite once Anisakidae larvae are removed (Lim et al., 2015).
To date, serological testing is applied almost exclusively in diagnosis
of allergic anisakidosis, thereby analyses of total and Anisakidae-spe-
ciﬁc IgE antibody levels are an integral part of the immunodiagnostic
approach (Baeza et al., 2004; Shimamura et al., 2016). Several allergens
have been characterised from A. simplex (Fæste et al., 2014), with Ani s
1 and Ani s 7 being major allergens found in the excretory-secretory
(ES) products (Anadón et al., 2010). Nonetheless, conﬁrmation of ani-
sakidosis cases only based on testing of total serum IgE level and pre-
sence of Anisakidae-speciﬁc IgE antibodies is very challenging since
respective immunoassays are often questioned for their diagnostic re-
liability. Speciﬁcity of parasite-speciﬁc IgE-tests is often low because
numerous helminths, other than the anisakid nematodes stimulate IgE
synthesis; furthermore IgE responses induced by environmental, food or
helminth allergens share common immunological properties (Yman,
2000). In comparison to other immunoglobulin classes, in particular
IgG, half-life of IgE antibodies is extremely short (2–3 days), which in
turn signiﬁcantly aﬀects sensitivity and reproducibility of IgE-tests
(Lawrence et al., 2017). In mice, a low anti-Ani s 7 IgE antibody re-
sponse was induced subsequent to intraperitoneal challenge of mice
with alive but not dead Anisakidae L3 larvae, this reaction peaked on
day thirty post infection and declined rapidly (Anadón et al., 2009).
Overall, current serodiagnosis of human parasitoses mostly relies on
parasite-speciﬁc IgG detection assays where the antigen is one of the
main factors that has the highest inﬂuence on both test sensitivity and
speciﬁcity. To date, the necessity for a reliable Anisakidae-speciﬁc IgG
detection assay is mainly based on the need of avoiding unnecessary
surgery resulting from preoperative misdiagnosis of the aetiology of the
gastrointestinal pain.
So far, to our knowledge, no study has been done on the com-
parative assessment of the IgG responses in anisakidosis patients against
crude or ES antigens from diﬀerent Anisakidae parasites.
2. Material and methods
2.1. Ethics statement
Rabbits purchased from the Center for Experimental Medicine
(Katowice, Poland) were housed under standard conditions and
experiments were conducted under the approval of the Local Ethical
Commission for Animal Experimentation (licence no: 66/2012).
Concerning sera from Spanish patients, informed consent was ob-
tained in all cases with approval of ethical committee (University
Hospital La Paz-FIBHULP, Madrid, Spain; Carballeda-Sangiao et al.,
2016).
The other human sera tested in this study were taken from a pre-
existing biological collection at the Institute of Parasitology in Bern
(University of Bern, Switzerland). These sera have been previously used
in similar studies (serodiagnosis of human parasitoses) which have,
respectively, been ethically approved by local committees (Pﬁster et al.,
1999; Müller et al., 2007; Gottstein et al., 2014).
2.2. Anisakidae antigens
2.2.1. Anisakidae L3 larvae collection and preparation of crude and ES
antigens
Encapsulated or free L3 larvae of A. simplex were collected from the
abdominal cavity walls and from visceral organs of Atlantic mackerel
(Scomber scombrus). Encapsulated P. decipiens and C. osculatum L3 larvae
were obtained from ﬁllets of Atlantic cod (Gadus morhua) and from li-
vers of Baltic cod (Gadus morhua callarias), respectively. Anisakidae
larvae were puriﬁed by successive washes with sterile 0.01M phos-
phate-buﬀered saline solution (PBS, pH 7.4). Anisakidae parasites were
then genetically analysed for species identiﬁcation by using PCR-re-
striction fragment length polymorphism (PCR-RFLP) (Zhu et al., 1998).
For A. simplex and C. osculatum, ES antigens were prepared by in-
cubation of viable L3 larvae in sterile PBS (∼200 larvae, equivalent to
∼0.6 g in 7ml PBS). For P. decipiens, approximately 100 larvae
(equivalent to ∼2.5 g) were cultured under sterile conditions in 20ml
sterile PBS. After completion of the incubation period (12 h at 37 °C),
larvae were removed. The media containing ES products were collected
and centrifuged at 20′000 g for 15min at 4 °C. Supernatants were sub-
jected to ultraﬁltration using polyether sulfone membrane of 3 K mo-
lecular weight cut-oﬀ at 4 °C (Thermo Fisher Scientiﬁc, Rockford, IL,
U.S.A.).
Crude extracts of A. simplex, C. osculatum and P. decipiens were
prepared as follows: ∼0.6 g of larvae which have been previously
collected from culture media were homogenized with 10ml of sterile
PBS in a small mortar. Afterwards, lysates were transferred to 15ml
Falcon tubes, sonicated in ice (10 μm amplitude for 30 s) and incubated
for 1 h at 4 °C. Supernatants were collected after centrifuging at
20′000 g for 15min at 4 °C.
To avoid proteolytic degradation, a protease inhibitor cocktail
(Sigma, St. Louis, MO, U.S.A.) was added (100U/ml) to ES and crude
extracts. Protein concentrations were determined using Bradford assay
(BioRad, Hercules, CA, U.S.A.) and antigens were stored at−20 °C until
use.
2.2.2. Cloning, expression and puriﬁcation of recombinant Ani s1 and rAni
s7
The truncated forms of the two A. simplex allergens: Ani s 1 and 7
(Ibarrola et al., 2008; Rodríguez et al., 2008) were recombinantly ex-
pressed according to our previously described protocol (Boubaker et al.,
2014).
2.3. Sera
2.3.1. Rabbit sera
Rabbits were immunised by intramuscular injection of 2.0 mg of A.
simplex-ESAg emulsiﬁed with Freund's complete adjuvant (Sigma, St
Louis, MO, U.S.A.), followed by three booster injections at days 14, 28,
and 56. Hyperimmune sera were obtained two weeks after the last in-
jection. Preimmune serum was taken before immunisation and used as
negative control.
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2.3.2. Human sera
- Healthy blood donors: 18 serum samples of healthy blood donors
were used to determine cut-oﬀ values.
- Sera from patients exposed to anisakids: 15 serum samples were ob-
tained from Spanish patients with symptoms of anisakidosis and
having Anisakidae-speciﬁc IgE antibodies. More detailed informa-
tion on the patients is given in Supplementary Table S1.
- Sera from patients with other parasitoses: to assess the degree of cross-
reactivity of diﬀerent ELISAs regarding other parasitic diseases, a
total of 61 serum samples were collected from patients with 13
diﬀerent parasitoses including cystic echinococcosis; alveolar echi-
nococcosis; cysticercosis; ﬁlariasis; strongyloidiasis; ascariasis; tox-
ocariasis; trichinellosis; fasciolosis; schistosomiasis; amoebiasis;
leishmaniasis and malaria.
2.4. SDS–PAGE and Western blot (WB)
Crude and ES antigens from A. simplex, P. decipiens and C. osculatum
were analysed by 4–15% gradient SDS-PAGE (BioRad, Hercules, CA,
U.S.A.) under reducing conditions (Laemmli, 1970) and gels were
stained with colloidal Coomassie G-250 (PageBlue, Thermo Fisher
Scientiﬁc, Rockford, IL, U.S.A.).
For WB analyses, ES antigens from the 3 species were ﬁrst separated
by 4–15% gradient SDS-PAGE and then transferred onto a 0.45 μm ni-
trocellulose membrane (Amersham Protran, GE Healthcare, Glattbrugg,
Switzerland). Three nitrocellulose strips loaded with diﬀerent ES were
separately incubated with rabbit anti-A. simplex-ESAg hyperimmune
serum diluted 1:500. Three additional strips were incubated with pre-
immune rabbit serum. The anti-rabbit IgG antibody conjugated to al-
kaline phosphatase (Sigma, Baar, Switzerland) was used as secondary
antibody.
SDS-PAGE and WB proﬁles were examined based on quantitative
densitometric analysis using Bio-1D software (ver. 15.07, Vilber
Lourmat, Marne-la-Vallée, France).
2.5. ELISA
Diagnostic performances of the three ES antigens and the two re-
combinant allergens were assessed separately by ELISA. In addition, we
also evaluate the mixture (1:1:1 by protein content) of the three ES
antigens (Mix-ESAgs).
ELISAs were basically performed as described earlier (Gottstein
et al., 1983; Müller et al., 1989). Brieﬂy, 96-well plates were coated for
overnight at 4 °C with diﬀerent antigens diluted into 0.05M carbonate
buﬀer, pH 9.6. The optimal concentration of each antigen was estab-
lished by checker-board titration and was as follow: 9 μg/ml for A.
simplex ES, 1.6 μg/ml for P. decipiens ES, 0.85 μg/ml for C. osculatum ES;
for rAni s 1 and rAni s 7, a concentration of 1 μg/ml was used, re-
spectively. Mix-ESAgs was prepared using the same concentration as in
individual assays. The sera were diluted 1:100 and the anti-human-IgG-
alkaline phosphatase conjugate (Sigma, Baar, Switzerland) was diluted
1:800. Absorbance values (A405nm) were measured using a Magellan
plate reader (Tecan, Männedorf, Switzerland).
2.6. Statistical analyses
The receiver operator characteristic (ROC) curve analyses were
performed to determine optimal cut-oﬀ values for diﬀerent ELISAs
(Supplementary Table S2) using NCSS software (ver. 11.0.13, NCSS,
LLC. Kaysville, Utah, U.S.A., ncss.com/software/ncss). For each ELISA,
the cut-oﬀ value was adjusted in order to achieve an optimal sensitivity
by testing 15 sera from anisakidosis patients without losing the max-
imal speciﬁcity (100%) by testing 18 blood donor sera.
For each ELISA, the distribution of A405 nm values in the diﬀerent
groups (see section 2.3.2) of sera tested in the each ELISA was displayed
on a dot plots graph.
3. Results
3.1. SDS–PAGE and WB analyses of ES and crude antigens from A.
simplex, P. decipiens and C. osculatum
The SDS-PAGE proﬁles of ES and crude antigens from A. simplex, P.
decipiens and C. osculatum are shown in Fig. 1. For both ES and crude
antigens, protein bands were in the 7–241 kDa range. Multiple banding
patterns of A. simplex and P. decipiens crude extracts were similar,
whereas C. osculatum crude antigen was slightly diﬀerent and char-
acterised by smaller number of major bands located in the range of
40–51 kDa. Conversely, patterns of ES were clearly distinct between A.
simplex, P. decipiens and C. osculatum.
In WB, the rabbit IgG polyclonal antibodies raised against A. simplex
ES reacted in a distinctive manner with all three ES antigens (Fig. 2).
While ES antigen from A. simplex and P. decipiens have similar reaction
patterns; the pattern of C. osculatum ES antigen was distinct and basi-
cally characterised by two major bands corresponding to proteins with
approximate sizes of 230 kDa and 15 kDa, respectively.
3.2. Diagnostic sensitivity of the IgG-ELISAs
Preliminary IgG-ELISA-based evaluations of crude antigens using
selected samples from the above-described panel of anisakidosis and
non-anisakidosis patients' sera (see section 2.3.2) revealed that these
antigens did not fulﬁll the diagnostic criteria particularly as far as the
Fig. 1. Colloidal Coomassie-stained 4–15% SDS-PAGE analysis of crude (CR) and excretory-secretory (ES) antigens prepared from A. simplex, P. decipiens and C.
osculatum. Densitometric analysis and molecular weights (MW) quantiﬁcation presented in kilodaltons (kDa) on the SDS-PAGE gels performed by Bio-1D software.
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speciﬁcity of the analyses are concerned (data not shown). Accordingly,
we decided to concentrate our assessment of the diagnostic perfor-
mance on those ELISAs that contained individual preparations, or a
mix, of ES antigens and on recombinant antigens rAni s 1 and 7.
Respective ELISAs were named as follow: A. simplex-ESAg-ELISA, P.
decipiens-ESAg-ELISA, C. osculatum-ESAg-ELISA, Mix-ESAgs-ELISA, rAni
s 1-ELISA and rAni s 7-ELISA. For each ELISA, the diagnostic cut-oﬀ
A405 nm values were calculated based on ROC analysis and are listed in
Supplementary Table S2.
In order to assess the diagnostic sensitivity of the six ELISAs listed
above; we tested 15 sera from Spanish patients with clinically diag-
nosed allergic anisakidosis (Table 1). Detailed results demonstrating the
immunoreactivity of serum IgG in each of the six tests is presented in
Supplementary Table S3.
Both C. osculatum-ESAg-ELISA and Mix-ESAgs-ELISA reached a
sensitivity of 100%, while A. simplex-ESAg-ELISA and P. decipiens-ESAg-
ELISA displayed a sensitivity of 93% and 67%, respectively. Ten out of
15 cases of anisakidosis were positive in all three ELISAs based on ES
antigen from A. simplex, P. decipiens and C. osculatum, respectively
(Supplementary Table S3); A405 nm values of 9 sera out of these 10 were
higher in C. osculatum-ESAg-ELISA than in A. simplex-ESAg-ELISA or P.
decipiens-ESAg-ELISA (Supplementary Table S3 and Fig. 3). The lowest
sensitivities of 53% and 60% were obtained for the rAni s 1-ELISA and
rAni s 7-ELISA, respectively (Table 1).
3.3. Speciﬁcity of the IgG-ELISAs
Speciﬁcity of the six IgG-ELISAs for serodiagnosis of human anisa-
kidosis was investigated by testing 61 sera from patients with other
parasitoses (caused by cestodes, nematodes, trematodes and protozoan
parasites).
Among the ES antigens tested, Mix-ESAgs and A. simplex ESAg dis-
played the lowest speciﬁcities of 44% and 57%, respectively (Table 2).
The P. decipiens-ESAg-ELISA provided the highest speciﬁcity of 93%,
immediately followed by the C. osculatum-ESAg-ELISA exhibiting a 89%
speciﬁcity.
As shown in Table 2, sera from individuals suﬀering from cystic
echinococcosis, alveolar echinococcosis, strongyloidiasis and ascariasis,
represented the major source of cross-reactions in the A. simplex-ESAg-
ELISA. In contrast, no cross-reactivity with the tested cestode infections
(cystic echinococcosis, alveolar echinococcosis and cysticercosis) was
detected with ES antigen from P. decipiens or from C. osculatum, re-
spectively.
For the C. osculatum ESAg-ELISA, a high degree of cross-reactivity
was particularly observed with sera from toxocariasis patients
(Table 2).
Speciﬁcities of the rAni s 1-ELISA and the rAni s 7-ELISA were 89%
and 67%, respectively (Table 2). All sera that were cross-reacting with
rAni s 1 exhibited only a borderline positivity (Supplementary Table S4
and Fig. 3). In contrast, 5 out of the 20 cross-reactions observed in rAni
s 7-ELISA were characterised by high A405 nm values ranging between
approximately 3 to 4 times the cut-oﬀ A405 nm value (Supplementary
Table S4).
All A405 nm values from the IgG-ELISAs are listed in Supplementary
Table S3, Supplementary Table S4 and a dot plot graph illustrating the
distribution of these values is shown in Fig. 3.
4. Discussion
Although human anisakidosis has been identiﬁed long time ago as a
medical problem of global importance, the current diagnostic scheme of
this disease still includes an urgent need for a standardised serological
test, in particular an IgG-ELISA. Such an ELISA is essential in view of a
targeted serodiagnosis to speciﬁcally detect anisakidosis in an in-
dividual patient but also as a screening test within an analytical spec-
trum suitable for diversiﬁed serological examinations of helminth in-
fections in humans. Our present study therefore was aimed at the
development of an Anisakidae-speciﬁc IgG-ELISA. For this purpose, we
simultaneously assessed and compared the diagnostic performance of
diﬀerent ELISAs containing ES antigens from A. simplex, P. decipiens and
C. osculatum which were chosen as representative species from the three
genera of the Anisakidae family infectious for humans.
Pretesting of the ES antigens in Western blots using rabbit anti-A.
simplex-ESAg hyperimmune serum revealed similarities in the
Fig. 2. Reactivity of anti-A. simplex ES rabbit IgG
antibodies to ES antigens from A. simplex, P. decipiens
and C. osculatum analysed by Western blot; with its
densitometric analysis and molecular weights (MW)
quantiﬁcation presented in kilodaltons (kDa) (Bio-1D
software).
Nitrocellulose strips contained ES of A. simplex (strip
1 and 2), ES of P. decipiens (strip 3 and 4) and ES of C.
osculatum ES (strip 5 and 6). One strip from each ES
antigen (strips 1, 3 and 5) was incubated with hy-
perimmune serum from rabbit immunised with A.
simplex ESAg (Pos), whereas strips 2, 4 and 6 were
incubated with rabbit preimmune serum (Neg).
Table 1
Sensitivity testing of the six ELISAs with sera from patients suﬀering from anisakidosis.
Antigen used in the ELISA A. simplex- ES P. decipiens- ES C. osculatum-ES Mix- ESAgs rAni s 1 rAni s 7
N° of positive sera (n= 15) 14 10 15 15 8 9
Sensitivity (in percent) 93.33 66.67 100 100 53.33 60
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Fig. 3. Dot plot graph illustrating the distribution of A405 nm values of all tested human sera in the six ELISAs. Sera were divided in 4 groups: healthy human sera (NH
[HYPHEN]S), reference sera from anisakidosis patients (AnisH[HYPHEN]S), sera from patients with other parasitoses (OPH[HYPHEN]S
Table 2
Speciﬁcity testing of the six ELISAs with sera from patients suﬀering from parasitic infections other than anisakidosis.
Antigen used in the ELISA A. simplex- ES P. decipiens- ES C. osculatum-ES Mix- ESAgs rAni s 1 rAni s 7
Disease (a) N° Total N° of positive sera N° of positive sera N° of positive sera N° of positive sera N° of positivesera N° of positivesera
Type of infection/disease
Cestodes
Cystic echinococcosis 5 5 0 0 5 0 0
Alveolar echinococcosis 5 5 0 0 4 0 0
Cysticercosis 2 1 0 0 1 1 1
Nematodes
Filariasis 4 2 1 1 4 3 1
Strongyloidiasis 5 4 2 0 5 0 3
Ascariasis 5 4 0 2 4 1 3
Toxocariasis 5 2 0 4 4 0 1
Trichinellosis 5 0 0 0 0 0 2
Trematodes
Fasciolosis 5 0 0 0 2 0 0
Schistosomiasis 5 0 0 0 1 0 3
Protozoa
Amoebiasis 5 2 1 0 3 1 2
Leishmaniasis 5 1 0 0 1 1 3
Malaria 5 0 0 0 0 0 1
N° of positive sera (n = 61) 26 4 7 34 7 20
Speciﬁcity (in percent) 57.38 93.44 88.52 44.26 88.52 67.21
a Total number of tested sera representing individual diseases.
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immunoreactivity banding patterns for A. simplex and P. decipiens (see
Fig. 2). C. osculatum ES antigen also cross-reacted with anti-A. simplex-
ESAg antibodies, however, the respective banding pattern was clearly
distinct. This observation is in line with molecular phylogeny inferred
from mitochondrial DNA sequences where Anisakis spp. and Pseudo-
terranova spp. were clustered in the same clade, while Contracaecum
spp. appeared in a separate clade (Nadler and Hudspeth, 2000; Nadler
et al., 2005). Despite this apparent distinctness, however, ES antigen
from C. osculatum surprisingly best met the criteria relevant for a reli-
able serodiagnosis of human anisakidosis. In this respect, we consider
the following ﬁndings as most important: (i) as demonstrated in the
Western blot incubated with anti-A. simplex-ESAg hyperimmune serum,
C. osculatum ES antigen contain strong antigenic epitopes that seem to
be shared between diﬀerent Anisakidae species (see Fig. 2). (ii) Com-
paratively, the C. osculatum ES antigen exhibited the most balanced
ratio between serodiagnostic sensitivity and speciﬁcity in our IgG-
ELISA (see Tables 1 and 2). (iii) Cross-reactions of C. osculatum ES
antigen with sera from patients suﬀering from other helminth infections
were restricted to a few sera from toxocariasis, ascariasis, and ﬁlariasis
patients (see Table 2). To a certain extent, false positive cases due to
such antibody cross-reactions can be discriminated from real anisaki-
dosis cases by including complementary serological testings, i.e. ELISAs
for serodiagnosis of toxocariasis, ascariasis, and ﬁlariasis, respectively.
Furthermore, the interpretation of the results from the C. osculatum-
ESAg-ELISA may be facilitated by considering anamnestic information
about the medical history of the patient associated with a possible
consumption of ﬁsh/seafood. Finally, conﬁrmation of allergic reactions
possibly associated with production of Anisakidae-speciﬁc IgE anti-
bodies to be determined by previously described methods (Anadón
et al., 2010; Carballeda-Sangiao et al., 2016; Mattiucci et al., 2017) may
provide complementary information in order to verify the results ob-
tained from the C. osculatum-ESAg-ELISA. In summary, we expect that
the combination of the entire serological and anamnestic data listed
above will provide suﬃcient information allowing reliable diagnosis of
anisakidosis in human patients.
Basically, the use of a mix of diﬀerent antigen preparations can be a
valuable strategy to improve the sensitivity of an ELISA-based serology
as e.g. demonstrated for serodiagnosis of human alveolar echino-
coccosis (Gottstein et al., 1993). In our study however, this strategy
turned out to be not recommendable mainly because the exclusive use
of C. osculatum ES antigen as antigenic agent in ELISAs already allowed
serodiagnosis of human anisakidosis with a maximal sensitivity (100%).
Furthermore, the mix of all three ES antigen preparations exhibited a
much lower speciﬁcity (44%) as compared to the ES products from C.
osculatum alone (89%).
In our study, we also investigated previously described recombinant
allergens Ani s 1 and Ani s 7 from A. simplex (Ibarrola et al., 2008;
Rodríguez et al., 2008) regarding their suitability in IgG-ELISA-based
serodiagnosis of human anisakidosis. We decided to test these allergens
because they had demonstrated a relatively high sensitivity in IgE-
ELISA-based diagnosis of cases of allergic anisakidosis (Moneo et al.,
2000; Rodríguez et al., 2008; Anadón et al., 2010; Carballeda-Sangiao
et al., 2016). However, in the present study, these antigens proved to be
insuﬃciently sensitive to justify their serodiagnostic application on an
IgG-ELISA basis.
In conclusion, our study showed that, based on serum IgG detection,
ﬁrstly ES antigens from diﬀerent Anisakidae species performed basi-
cally better than recombinant A. simplex allergens rAni s 1 and 7.
Secondly, among the three ES antigens tested, C. osculatum yielded the
best diagnostic performance regarding optimised diagnostic sensitivity
and speciﬁcity. Nevertheless, since the present study included only a
limited number of sera from human anisakidosis patients, and since this
patients' cluster covered only a distinct geographical region (Spain), we
consider our study as an explorative step towards the identiﬁcation,
evaluation and preliminary validation of antigens which should pro-
spectively be further evaluated for the serodiagnosis of human
anisakidosis, with a special focus on the C. osculatum ES antigen. From
current literature it can be concluded that, for many geographic areas,
symptomatic anisakidosis is frequently caused by A. simplex as e.g. re-
ported in Japan (Umehara et al., 2007) and also in Spain (Repiso Ortega
et al., 2003). Referring to the report from Spain (Repiso Ortega et al.,
2003), we assume that our Spanish panel of C. osculatum-ESAg-ELISA-
positive sera most likely originated from patients with an A. simplex
infection. Thus, we assume that the C. osculatum-ESAg-ELISA allows a
reliable diagnosis of A. simplex infections, but not necessarily of infec-
tions with the closely related Pseudoterranova, and Contracaecum spe-
cies. Accordingly, extended serological examinations of cases with a
diversiﬁed underlying aetiology determined on the Anisakidae species
level will have to clarify if the diagnostic potential of the C. osculatum-
ESAg-ELISA covers the entire spectrum of symptomatic anisakidosis in
humans. Furthermore, future studies will have to address the question if
recombinant analogues from predominant 230 kDa and 15 kDa C. os-
culatum-ES antigens (see Western blot in Fig. 2) will be suited for ani-
sakidosis serology. In preliminary studies, particularly the 15 kDa an-
tigen consistently exhibited a strong immunoreactivity with sera from
patients with suspected anisakoidosis (data not shown). However, such
an approach involving recombinant antigen production will be only
realistic if the antigenicity of the protein is determined by peptide
structures instead of sugar residues often representing covalently linked
antigenic components of nematode ES proteins (Maizels et al., 1987;
Dell et al., 1999). Furthermore, such an approach will also rely on a
sophisticated mass spectrometrical determination of the amino acid
sequence from the 15 kDa antigen to obtain the genetic information as a
basis for recombinant production of this protein.
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